Flint J, Kendler KS
Two have regulatory histories worth knowing: BPI Labs received an FDA warning letter in March 2025, and Olympia Pharmaceuticals received an FDA Form 483 in May 2024
GLP-1 receptor agonists were associated with markedly lower risks of major adverse cardiovascular events, progression of kidney disease, venous thromboembolism, and all-cause mortality compared to DPP-4 inhibitor therapy
Consistent with the toxicity of isoniazid in slow acetylators, there is an increased incidence of other drug toxicities in subjects carrying defective alleles, such as lupus erythematosus in patients treated with hydralazine or procainamide (Sim et al., 1988), and haemolytic anemia and inflammatory bowel disease after treatment with sulfasalazine (Chen et al., 2007)
Hemoglobin A1c Hemoglobin A1c tests are essential for assessing how well your body manages blood sugar over a few months
The daily battle to do it all AND still get healthy meals and exercise into our routine can be tough, and this can wreak havoc on your health